ASX:PIQ Proteomics International Laboratories (PIQ) Stock Price, News & Analysis → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free PIQ Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume126,546 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Proteomics International Laboratories alerts: Email Address Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. About Proteomics International LaboratoriesProteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. The company was founded in 2001 and is based in Perth, Australia.Read More Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. PIQ Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive PIQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Proteomics International Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:PIQ CUSIPN/A CIKN/A Webwww.proteomics.com.au Phone61 8 9389 1992FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,900,000.00 Net Margins-194.61% Pretax MarginN/A Return on Equity-97.26% Return on Assets-49.23% Debt Debt-to-Equity Ratio0.89 Current Ratio4.34 Quick Ratio2.51 Sales & Book Value Annual Sales$3.03 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow13.15 Book ValueA$0.04 per share Price / BookN/AMiscellaneous Outstanding Shares130,890,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.59 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesDr. Richard John Lipscombe M.A.MA (Oxford), Ph.D., Ph.D., (London), Co-Founder, MD & DirectorMs. Jacqueline GrayChief Financial OfficerMr. John Chuck MorrisonHead of Business DevelopmentDr. Scott BringansHead of ResearchDr. Pearl TanHead of LogisticsMr. Vikesh MalikChief Commercialisation OfficerDr. Kirsten PetersHead of Clinical StudiesMs. Karen Teresa Logan ACISB.Com., BCom, DipAppCorpGov, F Fin, FCIS, FC, Company SecretaryMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All CompetitorsInsidersRichard LipscombeSold 2,631,579 sharesTotal: $2.00 M ($0.76/share) PIQ Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Proteomics International Laboratories own? Based on aggregate information from My MarketBeat watchlists, some companies that other Proteomics International Laboratories investors own include Woolworths Group (WOW), Patrys (PAB), Insurance Australia Group (IAG) and Bendigo and Adelaide Bank (BEN). This page (ASX:PIQ) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Proteomics International Laboratories Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.